PMDA drug package insert
ビペリデン塩酸塩錠1mg「ヨシトミ」
PMDA Prescription drug · 田辺ファーマ株式会社 · package insert Apr 22, 2026
Key facts
| Brand names | ビペリデン塩酸塩錠1mg「ヨシトミ」, ビペリデン塩酸塩散1%「ヨシトミ」 |
|---|---|
| Nonproprietary names | ビペリデン塩酸塩 |
| Companies | 製造販売元／田辺ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | パーキンソン症候群治療剤 |
| Therapeutic category codes | 871162 |
| YJ codes | 1162001F1082, 1162001B1048 |
| Approval numbers | 23000AMX00165, 23000AMX00164 |
| Package insert edition | 第2版 |
| Package insert date | Apr 22, 2026 |
| PMDA document key | 400315_1162001B1048_1 |
| PMDA company code | 400315 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: